Mariusz A. Nowak

Krasińskiego 8 St
Katowice, SL 40019, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 75 publications

Effectiveness of pelvic floor rehabilitation after radical prostatectomy and continence recovery in relation to surgical technique.

Effectiveness of pelvic floor rehabilitation after radical prostatectomy and continence recovery in relation to surgical technique.

Journal: Scientific reports

Published: December 03, 2025

Continence Recovery After Radical Prostatectomy: Personalized Rehabilitation and Predictors of Treatment Outcome.

Continence Recovery After Radical Prostatectomy: Personalized Rehabilitation and Predictors of Treatment Outcome.

Journal: Diagnostics (Basel, Switzerland)

Published: August 27, 2025

Lipidogram profiles in patients with Graves' and Basedow's disease with and without orbitopathy.

Lipidogram profiles in patients with Graves' and Basedow's disease with and without orbitopathy.

Journal: Endokrynologia Polska

Published: August 19, 2025

Phenotypic stratification predicts the pace, but not the outcome, of continence recovery after radical prostatectomy.

Phenotypic stratification predicts the pace, but not the outcome, of continence recovery after radical prostatectomy.

Journal: PloS one

Published: July 14, 2025

Pelvic Floor Rehabilitation After Prostatectomy: Baseline Severity as a Predictor of Improvement-A Prospective Cohort Study.

Pelvic Floor Rehabilitation After Prostatectomy: Baseline Severity as a Predictor of Improvement-A Prospective Cohort Study.

Journal: Journal of clinical medicine

Published: May 28, 2025

Antibodies against the receptor for insulin-like growth factor 1 (IGF-1RAb), insulin-like growth factor 1 (IGF-1), and insulin-like growth factor binding protein 3 (IGFBP-3) in the serum of patients with Graves' and Basedow's disease with and without orbitopathy.

Antibodies against the receptor for insulin-like growth factor 1 (IGF-1RAb), insulin-like growth factor 1 (IGF-1), and insulin-like growth factor binding protein 3 (IGFBP-3) in the serum of patients with Graves' and Basedow's disease with and without orbitopathy.

Journal: Endokrynologia Polska

Published: August 29, 2024

The position of monoclonal antibodies and small molecules in the treatment of thyroid orbitopathy.

The position of monoclonal antibodies and small molecules in the treatment of thyroid orbitopathy.

Journal: Endokrynologia Polska

Published: January 01, 2024

Adrenal tumours and subclinical adrenal hyperfunction.

Adrenal tumours and subclinical adrenal hyperfunction.

Journal: Endokrynologia Polska

Published: January 01, 2024

Differential diagnosis of thyroid orbitopathy - diseases mimicking the presentation or activity of thyroid orbitopathy.

Differential diagnosis of thyroid orbitopathy - diseases mimicking the presentation or activity of thyroid orbitopathy.

Journal: Endokrynologia Polska

Published: November 09, 2023

Preliminary Research on the Effect of Hyperbaric Oxygen Therapy in Patients with Post-COVID-19 Syndrome.

Preliminary Research on the Effect of Hyperbaric Oxygen Therapy in Patients with Post-COVID-19 Syndrome.

Journal: Journal of clinical medicine

Published: November 10, 2022

Comparison of Physicochemical, Mechanical, and (Micro-)Biological Properties of Sintered Scaffolds Based on Natural- and Synthetic Hydroxyapatite Supplemented with Selected Dopants.

Comparison of Physicochemical, Mechanical, and (Micro-)Biological Properties of Sintered Scaffolds Based on Natural- and Synthetic Hydroxyapatite Supplemented with Selected Dopants.

Journal: International journal of molecular sciences

Published: April 04, 2022

[Optimization of the treatment of moderate to severe and active thyroid orbitopathy considering the recommendations of the European Group on Graves' Orbitopathy (EUGOGO) [Optymalizacja leczenia umiarkowanej do ciężkiej i aktywnej orbitopatii tarczycowej z uwzględnieniem zaleceń European Group on Graves' Orbitopathy (EUGOGO)]].

[Optimization of the treatment of moderate to severe and active thyroid orbitopathy considering the recommendations of the European Group on Graves' Orbitopathy (EUGOGO) [Optymalizacja leczenia umiarkowanej do ciężkiej i aktywnej orbitopatii tarczycowej z uwzględnieniem zaleceń European Group on Graves' Orbitopathy (EUGOGO)]].

Journal: Endokrynologia Polska

Published: January 11, 2022

Showing 1-12 of 75

Last Updated: 09/26/2026